Next-generation cancer tests are being developed here in Houston, and the HBJ pulled back the curtain on how one partnership ...
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...
Tempus and NYU Langone Health have formed a multi-year strategic collaboration to advance cancer research through molecular profiling and data-driven insights. The partnership will support NYU Langone ...
CHICAGO, ILLINOIS, UNITED STATES OF AMERICA, June 2, 2024 /EINPresswire.com/ -- Massive Bio, a renowned leader in AI-driven oncology solutions and Mika Health, the ...
Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...
News-Medical.Net on MSN
Novel liquid biopsy technology could advance cancer diagnostics and monitoring
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple ...
Delays in time to first lenalidomide prescription fill for multiple myeloma. Preliminary results of a combined home and rural outpatient clinic-based infusion program through the Veterans Health ...
EGFR mutation testing is crucial for NSCLC treatment, but global disparities exist in access to comprehensive molecular diagnostics. Third-generation inhibitors and combination regimens improve ...
The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback